Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Ablynx    ABLX   BE0003877942

ABLYNX (ABLX)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Upcoming events on ABLYNX
01/08/18 J.P. Morgan Health Care Conference
02/17/18 Credit Suisse London Health Care Conference
02/22/18 FY 2017 Earnings Release
05/17/18 Q1 2018 Earnings Release
Past events on ABLYNX
12/12/17 | 04:00pm American Society of Hematology Meeting - Additional Data
12/12/17 | 01:30pm American Society of Hematology Meeting - Abstract#LBA-1
11/17/17 Bryan, Garnier & Co Healthcare Conference
11/16/17 | 03:00pm Jefferies London Health Care Conference
Upcoming sector events for ABLYNX
12/14/17 | 03:00pm ALNYLAM PHARMACEUTICALS, INC. : BMO Capital Markets Prescriptions for Success Healthcare Conference
12/14/17 | 05:00pm NEUROCRINE BIOSCIENCES, INC. : BMO Capital Markets Prescriptions for Success Healthcare Conference
12/14/17 | 07:30pm SAGE THERAPEUTICS INC : BMO Capital Markets Prescriptions for Success Healthcare Conference
12/14/17 | 07:30pm IONIS PHARMACEUTICALS INC : BMO Capital Markets Prescriptions for Success Healthcare Conference
Past sector events for ABLYNX
12/12/17 JUNO THERAPEUTICS INC : American Society of Hematology Meeting - Abstract #4471
12/12/17 JUNO THERAPEUTICS INC : American Society of Hematology Meeting - Abstract #3889
12/12/17 JUNO THERAPEUTICS INC : American Society of Hematology Meeting - Abstract #5048
12/12/17 INCYTE CORPORATION : American Society of Hematology Meeting - Abstract #4204
Annual publications
Previous yearNext Year
Annual results2014201520162017 (e)2018 (e)
Sales
Million €
Released
Forecast
Spread
49,3
47,0
4,8%
77,5
71,6
8,3%
85,2
80,7
5,5%

64,7

60,1
Operating income (EBITDA)
Million €
Released
Forecast
Spread
-14,7
-21,8
32%
-18,6
-20,3
8,4%
-26,4
-20,7
-27%

-48,9

-55,9
Operating profit (EBIT)
Million €
Released
Forecast
Spread
-16,2
-20,0
19%
-20,0
-22,0
9,3%
-28,6
-20,8
-37%

-56,2

-67,2
Pre-Tax Profit (EBT)
Million €
Released
Forecast
Spread
-12,7
-15,3
17%
-54,5
-21,2
-158%
-1,09
7,76
-114%

-66,7

-87,7
Net income
Million €
Released
Forecast
Spread
-12,7
-23,2
45%
-54,5
-24,2
-125%
-1,09
-4,80
77%

-73,4

-64,9
EPS
 €
Released
Forecast
Spread
-0,25
-0,37
32%
-1,00
-0,47
-114%
-0,02
-0,16
88%

-1,03

-0,99
Announcement Date02/26/201502/25/201602/23/2017

Quarterly / Semiannualy publications
Previous yearPrevious periodNext periodNext Year
Quarterly resultsS1
2016
S2
2016
S1
2017
Q3
2017 (e)
Q4
2017 (e)
Sales
Million €
Released
Forecast
Spread


31,7
34,0
-6,8%
34,7


10,0

15,0
Operating income (EBITDA)
 
Released
Forecast
Spread










Operating profit (EBIT)
Million €
Released
Forecast
Spread

-19,0
-26,6
-11,6
-129%
-24,8
-18,0
-38%

-17,3

-12,9
Pre-Tax Profit (EBT)
Million €
Released
Forecast
Spread


-23,9
-14,7
-63%
-25,3





Net income
Million €
Released
Forecast
Spread


-23,9
-14,7
-63%






EPS
 €
Released
Forecast
Spread


-0,42
-0,30
-40%






Announcement Date02/23/201708/24/2017

© 2017 Thomson Reuters
© 2017 Factset
Net sales (Year) - Rate of surprise
Operating profit (Year) - Rate of surprise
EPS (Year) - Rate of surprise